Works matching Nonalcoholic steatohepatitis (NASH)

Results: 2110

Effect of pioglitazone, quercetin, and hydroxy citric acid on vascular endothelial growth factor messenger RNA (VEGF mRNA) expression in experimentally induced nonalcoholic steatohepatitis (NASH).

Published in:

Turkish Journal of Medical Sciences, 2015, v. 45, n. 3, p. 542, doi. 10.3906/sag-1404-136

By:

KRISHNA MOHAN, Surapaneni;
Priya VEERARAGHAVAN, Vishnu;
JAINU, Mallika

Publication type:

Article

In Vitro, In Vivo, and In Silico Investigation of Synbiotic‐Mediated Activation of PPAR‐α Curtails Nonalcoholic Steatohepatitis (NASH) in Wistar Rats by Inhibiting PNPLA3/SREBP1‐c Lead Inflammatory Injury of Hepatic Cells.

Published in:

Mediators of Inflammation, 2025, v. 2025, p. 1, doi. 10.1155/mi/9948679

By:

Sharma, Dixa;
Patel, Dhara;
Mandal, Palash;
Giovarelli, Mirella

Publication type:

Article

Predictive Factors for Nonalcoholic Steatohepatitis (NASH) in Patients with Nonalcoholic Fatty Liver Disease (NAFLD).

Published in:

Journal of Gastrointestinal & Liver Diseases, 2011, v. 20, n. 2, p. 153

By:

Fierbinteanu-Braticevici, Carmen;
Baicus, Cristian;
Tribus, Laura;
Papacocea, Raluca

Publication type:

Article

Nonalcoholic Steatohepatitis (NASH) and Atherosclerosis: Explaining Their Pathophysiology, Association and the Role of Incretin-Based Drugs.

Published in:

Antioxidants, 2022, v. 11, n. 6, p. 1060, doi. 10.3390/antiox11061060

By:

Galatou, Eleftheria;
Mourelatou, Elena;
Hatziantoniou, Sophia;
Vizirianakis, Ioannis S.

Publication type:

Article

Fibrogenesis and Carcinogenesis in Nonalcoholic Steatohepatitis (NASH): Involvement of Matrix Metalloproteinases (MMPs) and Tissue Inhibitors of Metalloproteinase (TIMPs).

Published in:

Cancers, 2014, v. 6, n. 3, p. 1220, doi. 10.3390/cancers6031220

By:

Isao Okazaki;
Takuji Noro;
Nobuhiro Tsutsui;
Eigoro Yamanouchi;
Hajime Kuroda;
Masayuki Nakano;
Hiroaki Yokomori;
Yutaka Inagaki

Publication type:

Article

Sugar-Sweetened Beverages and Artificially Sweetened Beverages Consumption and the Risk of Nonalcoholic Fatty Liver (NAFLD) and Nonalcoholic Steatohepatitis (NASH).

Published in:

Nutrients, 2023, v. 15, n. 18, p. 3997, doi. 10.3390/nu15183997

By:

Tseng, Tung-Sung;
Lin, Wei-Ting;
Ting, Peng-Sheng;
Huang, Chiung-Kuei;
Chen, Po-Hung;
Gonzalez, Gabrielle V.;
Lin, Hui-Yi

Publication type:

Article

The role of differentially expressed genes and immune cell infiltration in the progression of nonalcoholic steatohepatitis (NASH) to hepatocellular carcinoma (HCC): a new exploration based on bioinformatics analysis.

Published in:

Nucleosides, Nucleotides & Nucleic Acids, 2024, v. 43, n. 12, p. 1415, doi. 10.1080/15257770.2024.2310044

By:

Liu, Yang;
Yu, Xiaohan;
Wang, Yuegu;
Wu, Jinge;
Feng, Bo;
Li, Meng

Publication type:

Article

Exosomal microRNAs and Progression of Nonalcoholic Steatohepatitis (NASH).

Published in:

2022

By:

Qi, Xiaoyan;
Lai, Jinping

Publication type:

Literature Review

Inhibition of sodium glucose cotransporter 2 (SGLT2) delays liver fibrosis in a medaka model of nonalcoholic steatohepatitis (NASH).

Published in:

FEBS Open Bio, 2019, v. 9, n. 4, p. 643, doi. 10.1002/2211-5463.12598

By:

Goto, Ryo;
Kamimura, Kenya;
Shinagawa‐Kobayashi, Yoko;
Sakai, Norihiro;
Nagoya, Takuro;
Niwa, Yusuke;
Ko, Masayoshi;
Ogawa, Kohei;
Inoue, Ryosuke;
Yokoo, Takeshi;
Sakamaki, Akira;
Kamimura, Hiroteru;
Abe, Satoshi;
Nishina, Hiroshi;
Terai, Shuji

Publication type:

Article

Free fatty acid-based low-impedance liver image: a characteristic appearance in nonalcoholic steatohepatitis (NASH).

Published in:

European Radiology Experimental, 2020, v. 4, n. 1, p. 1, doi. 10.1186/s41747-019-0137-y

By:

Maruyama, Hitoshi;
Kobayashi, Kazufumi;
Kiyono, Soichiro;
Chiba, Tetsuhiro;
Kato, Naoya;
Ohtsuka, Masayuki;
Ito, Kazuyo;
Yamaguchi, Tadashi;
Shiina, Shuichiro

Publication type:

Article

Time course of western diet (WD) induced nonalcoholic steatohepatitis (NASH) in female and male Ldlr-/- mice.

Published in:

PLoS ONE, 2023, v. 18, n. 10, p. 1, doi. 10.1371/journal.pone.0292432

By:

Spooner, Melinda H.;
Garcia-Jaramillo, Manuel;
Apperson, K. Denise;
Löhr, Christiane V.;
Jump, Donald B.

Publication type:

Article

Methylenetetrahydrofolate reductase gene polymorphisms in patients with nonalcoholic steatohepatitis (NASH).

Published in:

Cell Biochemistry & Function, 2008, v. 26, n. 3, p. 291, doi. 10.1002/cbf.1424

By:

Sazci, Ali;
Ergul, Emel;
Aygun, Cem;
Akpinar, Gurler;
Senturk, Omer;
Hulagu, Sadettin

Publication type:

Article

Biopsy rate and nonalcoholic steatohepatitis (NASH) in patients with nonalcoholic fatty liver disease (NAFLD).

Published in:

Scandinavian Journal of Gastroenterology, 2020, v. 55, n. 6, p. 706, doi. 10.1080/00365521.2020.1766554

By:

Gerhardt, Florian;
Petroff, David;
Blank, Valentin;
Böhlig, Albrecht;
van Bömmel, Florian;
Wittekind, Christian;
Berg, Thomas;
Karlas, Thomas;
Wiegand, Johannes

Publication type:

Article

Prevalence and Correlates of Probable Nonalcoholic Steatohepatitis (NASH) in Pars Cohort Study.

Published in:

Archives of Iranian Medicine (AIM), 2024, v. 27, n. 11, p. 598, doi. 10.34172/aim.30020

By:

Nakhostin-Ansari, Amin;
Oskouie, Iman Menbari;
Aghajani, Reyhaneh;
Khadembashiri, Mohammad Mehdi;
Ahmadi, Mohammad;
Gandomkar, Abdollah;
Malekzadeh, Fatemeh;
Poustchi, Hossein;
Fattahi, Mohammad Reza;
Anushiravani, Amir;
Malekzadeh, Reza

Publication type:

Article

Study of Plasma Pentraxin Levels as a Novel Marker versus Liver Stiffness for Nonalcoholic Steatohepatitis (NASH) in Egyptian Patients.

Published in:

QJM: An International Journal of Medicine, 2024, v. 117, p. i130, doi. 10.1093/qjmed/hcae070.296

By:

Gadallah, Shaimaa Husein;
Badawy, Hanan Mahmoud;
Mohammed, Eslam Safwt;
Hassan, Hanan Emam;
Ghait, Ramy Samir;
Ghait, Shady Samir

Publication type:

Article

Fatty acid-binding protein-4 (FABP4) and matrix metalloproteinase-9 (MMP9) as predictive values for nonalcoholic steatohepatitis (NASH).

Published in:

Lipids in Health & Disease, 2023, v. 22, n. 1, p. 1, doi. 10.1186/s12944-022-01764-1

By:

Wagner, Jonas;
Kumar, Yogesh;
Lautenbach, Anne;
von Kroge, Philipp;
Wolter, Stefan;
Mann, Oliver;
Izbicki, Jakob;
Gagliani, Nicola;
Duprée, Anna

Publication type:

Article

Coordinated changes of gut microbiome and lipidome differentiates nonalcoholic steatohepatitis (NASH) from isolated steatosis.

Published in:

Liver International, 2020, v. 40, n. 3, p. 622, doi. 10.1111/liv.14316

By:

Qian, Minyi;
Hu, Haiyang;
Yao, Ying;
Zhao, Danyang;
Wang, Shilei;
Pan, Chuyue;
Duan, Xubin;
Gao, Yingsheng;
Liu, Jun;
Zhang, Yufei;
Yang, Song;
Qi, Lian‐Wen;
Wang, Lirui

Publication type:

Article

Lipidomic and transcriptomic analysis of western diet-induced nonalcoholic steatohepatitis (NASH) in female Ldlr -/- mice.

Published in:

PLoS ONE, 2019, v. 14, n. 4, p. 1, doi. 10.1371/journal.pone.0214387

By:

Garcia-Jaramillo, Manuel;
Spooner, Melinda H.;
Löhr, Christiane V.;
Wong, Carmen P.;
Zhang, Weijian;
Jump, Donald B.

Publication type:

Article

EFFECTS OF L-CARNITINE SUPPLEMENTATION ON BODY COMPOSITION IN PATIENTS WITH NONALCOHOLIC STEATOHEPATITIS (NASH).

Published in:

Current Topics in Nutraceutical Research, 2015, v. 13, n. 2, p. 71

By:

Amiri-Moghadam, Shirin;
Nematy, Mohsen;
Eghtesadi, Shayryar;
khalili, Mohammad;
Mojarrad, Majid;
Jazayeri, Shima;
Vosooghinia, Hasan;
Khosravi, Ahmad;
Salehi, Maryam;
Beheshti-Namdar, Ali

Publication type:

Article

1845-P: Maternal Overnutrition Causes DNA Alkylation in Fetal Liver, Suppresses FasL, and Upregulates HIF-1 Signaling Pathway in Neonatal Liver in Nonalcoholic Steatohepatitis (NASH)-Based Hepatocellular Carcinoma in Offspring.

Published in:

Diabetes, 2020, v. 69, p. N.PAG, doi. 10.2337/db20-1845-P

By:

TAKIYAMA, TAKAO;
BESSHO, RYOICHI;
SAWAMOTO, KAZUKI;
TAKIYAMA, YUMI

Publication type:

Article

1829-P: Aggravating Liver Lipid Accumulation and Fibrosis in Nonalcoholic Steatohepatitis Model of MS-NASH Mice by a Modified Amylin Diet.

Published in:

Diabetes, 2020, v. 69, p. N.PAG, doi. 10.2337/db20-1829-P

By:

ZHANG, GUODONG;
CHNG, KEEFE;
WANG, YIXIN

Publication type:

Article

Machine Learning Approach for Cardiovascular Death Prediction among Nonalcoholic Steatohepatitis (NASH) Liver Transplant Recipients.

Published in:

Healthcare (2227-9032), 2024, v. 12, n. 12, p. 1165, doi. 10.3390/healthcare12121165

By:

Fatemi, Yasin;
Nikfar, Mohsen;
Oladazimi, Amir;
Zheng, Jingyi;
Hoy, Haley;
Ali, Haneen

Publication type:

Article

Nonalcoholic Steatohepatitis (NASH) Is Associated with a Decline in Pancreatic Beta Cell (β-Cell) Function.

Published in:

Digestive Diseases & Sciences, 2015, v. 60, n. 8, p. 2529, doi. 10.1007/s10620-015-3627-7

By:

Siddiqui, Mohammad;
Cheang, Kai;
Luketic, Velimir;
Boyett, Sherry;
Idowu, Michael;
Patidar, Kavish;
Puri, Puneet;
Matherly, Scott;
Stravitz, Richard;
Sterling, Richard;
Sanyal, Arun

Publication type:

Article

Serum ferritin is a clinical biomarker in Japanese patients with nonalcoholic steatohepatitis (NASH) independent of HFE gene mutation.

Published in:

2010

By:

Yoneda, Masato;
Nozaki, Yuichi;
Endo, Hiroki;
Mawatari, Hironori;
Iida, Hiroshi;
Fujita, Koji;
Yoneda, Kyoko;
Takahashi, Hirokazu;
Kirikoshi, Hiroyuki;
Inamori, Masahiko;
Kobayashi, Noritoshi;
Kubota, Kensuke;
Saito, Satoru;
Maeyama, Shiro;
Hotta, Kikuko;
Nakajima, Atsushi

Publication type:

journal article

Orlistat Reverse Fatty Infiltration and Improves Hepatic Fibrosis in Obese Patients with Nonalcoholic Steatohepatitis (NASH).

Published in:

Digestive Diseases & Sciences, 2007, v. 52, n. 10, p. 2512, doi. 10.1007/s10620-006-9631-1

By:

Osamah Hussein;
Masha Grosovski;
Sorina Schlesinger;
Sergio Szvalb

Publication type:

Article

Population Pharmacokinetics of Morphine in Patients With Nonalcoholic Steatohepatitis (NASH) and Healthy Adults.

Published in:

CPT: Pharmacometrics & Systems Pharmacology, 2017, v. 6, n. 5, p. 331, doi. 10.1002/psp4.12185

By:

Pierre, V;
Johnston, CK;
Ferslew, BC;
Brouwer, KLR;
Gonzalez, D

Publication type:

Article

Considerations for Physiologically Based Modeling in Liver Disease: From Nonalcoholic Fatty Liver (NAFL) to Nonalcoholic Steatohepatitis (NASH).

Published in:

Clinical Pharmacology & Therapeutics, 2023, v. 113, n. 2, p. 275, doi. 10.1002/cpt.2614

By:

Murphy, William A.;
Adiwidjaja, Jeffry;
Sjöstedt, Noora;
Yang, Kyunghee;
Beaudoin, James J.;
Spires, Jessica;
Siler, Scott Q.;
Neuhoff, Sibylle;
Brouwer, Kim L.R.

Publication type:

Article

Innovative Molecular Targets and Therapeutic Approaches in Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis (NAFLD/NASH) 3.0.

Published in:

International Journal of Molecular Sciences, 2024, v. 25, n. 7, p. 4010, doi. 10.3390/ijms25074010

By:

Vairetti, Mariapia;
Colucci, Giuseppe;
Ferrigno, Andrea

Publication type:

Article

Therapeutic Effects of microRNAs on Nonalcoholic Fatty Liver Disease (NAFLD) and Nonalcoholic Steatohepatitis (NASH): A Systematic Review and Meta-Analysis.

Published in:

International Journal of Molecular Sciences, 2023, v. 24, n. 11, p. 9168, doi. 10.3390/ijms24119168

By:

Zhu, Yuezhi;
Tan, Jen Kit;
Wong, Sok Kuan;
Goon, Jo Aan

Publication type:

Article

Soluble Endoglin as a Potential Biomarker of Nonalcoholic Steatohepatitis (NASH) Development, Participating in Aggravation of NASH-Related Changes in Mouse Liver.

Published in:

International Journal of Molecular Sciences, 2020, v. 21, n. 23, p. 9021, doi. 10.3390/ijms21239021

By:

Igreja Sá, Ivone Cristina;
Tripska, Katarina;
Hroch, Milos;
Hyspler, Radomir;
Ticha, Alena;
Lastuvkova, Hana;
Schreiberova, Jolana;
Dolezelova, Eva;
Eissazadeh, Samira;
Vitverova, Barbora;
Najmanova, Iveta;
Vasinova, Martina;
Pericacho, Miguel;
Micuda, Stanislav;
Nachtigal, Petr

Publication type:

Article

Targeting of Secretory Proteins as a Therapeutic Strategy for Treatment of Nonalcoholic Steatohepatitis (NASH).

Published in:

International Journal of Molecular Sciences, 2020, v. 21, n. 7, p. 2296, doi. 10.3390/ijms21072296

By:

Kim, Kyeongjin;
Kim, Kook Hwan

Publication type:

Article

Overexpression of the Vitronectin V10 Subunit in Patients with Nonalcoholic Steatohepatitis: Implications for Noninvasive Diagnosis of NASH.

Published in:

International Journal of Molecular Sciences, 2018, v. 19, n. 2, p. 603, doi. 10.3390/ijms19020603

By:

Del Ben, Maria;
Overi, Diletta;
Polimeni, Licia;
Carpino, Guido;
Labbadia, Giancarlo;
Baratta, Francesco;
Pastori, Daniele;
Noce, Valeria;
Gaudio, Eugenio;
Angelico, Francesco;
Mancone, Carmine

Publication type:

Article

Required warfarin dose and time in therapeutic range in patients with diagnosed Nonalcoholic Fatty Liver Disease (NAFLD) or Nonalcoholic Steatohepatitis (NASH).

Published in:

PLoS ONE, 2021, v. 16, n. 9, p. 1, doi. 10.1371/journal.pone.0251665

By:

Wen, Xuerong;
Wang, Shuang;
Taveira, Tracey H.;
Akhlaghi, Fatemeh

Publication type:

Article

Cross-walk of the Chronic Liver Disease Questionnaire for Nonalcoholic Steatohepatitis (CLDQ-NASH) and the EuroQol EQ-5D-5L in patients with NASH.

Published in:

Health & Quality of Life Outcomes, 2023, v. 21, n. 1, p. 1, doi. 10.1186/s12955-023-02195-x

By:

Fishman, Jesse;
Higgins, Victoria;
Piercy, James;
Pike, James

Publication type:

Article

Atorvastatin decreases serum levels of advanced glycation endproducts (AGEs) in nonalcoholic steatohepatitis (NASH) patients with dyslipidemia: clinical usefulness of AGEs as a biomarker for the attenuation of NASH.

Published in:

Journal of Gastroenterology, 2010, v. 45, n. 7, p. 750, doi. 10.1007/s00535-010-0203-y

By:

Kimura, Yuki;
Hyogo, Hideyuki;
Yamagishi, Sho-ichi;
Takeuchi, Masayoshi;
Ishitobi, Tomokazu;
Nabeshima, Yoshitaka;
Arihiro, Koji;
Chayama, Kazuaki

Publication type:

Article

Gp78, an E3 Ubiquitin Ligase Acts as a Gatekeeper Suppressing Nonalcoholic Steatohepatitis (NASH) and Liver Cancer.

Published in:

PLoS ONE, 2015, v. 10, n. 3, p. 1, doi. 10.1371/journal.pone.0118448

By:

Zhang, Tianpeng;
Kho, Dhong Hyo;
Wang, Ying;
Harazono, Yosuke;
Nakajima, Kosei;
Xie, Youming;
Raz, Avraham

Publication type:

Article

A new method to induce nonalcoholic steatohepatitis (NASH) in mice.

Published in:

2019

By:

Savari, Feryal;
Mard, Seyyed Ali;
Badavi, Mohammad;
Rezaie, Anahita;
Gharib-Naseri, Mohammad Kazem

Publication type:

journal article

Single-cell resolved ploidy and chromosomal aberrations in nonalcoholic steatohepatitis-(NASH) induced hepatocellular carcinoma and its precursor lesions.

Published in:

Scientific Reports, 2022, v. 12, n. 1, p. 1, doi. 10.1038/s41598-022-27173-z

By:

Friemel, Juliane;
Torres, Irianna;
Brauneis, Elizabeth;
Thörner, Tim;
Schäffer, Alejandro A.;
Gertz, E. Michael;
Grob, Tobias;
Seidl, Kati;
Weber, Achim;
Ried, Thomas;
Heselmeyer-Haddad, Kerstin

Publication type:

Article

Current Status in Testing for Nonalcoholic Fatty Liver Disease (NAFLD) and Nonalcoholic Steatohepatitis (NASH).

Published in:

Cells (2073-4409), 2019, v. 8, n. 8, p. 845, doi. 10.3390/cells8080845

By:

Drescher, Hannah K.;
Weiskirchen, Sabine;
Weiskirchen, Ralf

Publication type:

Article

The effect of metformin and standard therapy versus standard therapy alone in nondiabetic patients with insulin resistance and nonalcoholic steatohepatitis (NASH): a pilot trial.

Published in:

Therapeutic Advances in Gastroenterology, 2009, v. 2, n. 3, p. 157, doi. 10.1177/1756283X09105462

By:

Shields, William W.;
Thompson, K.E.;
Grice, G.A.;
Harrison, S.A.;
Coyle, W.J.

Publication type:

Article

Resmetirom: The First Food and Drug Administration–Approved Medication for Nonalcoholic Steatohepatitis (NASH).

Published in:

2025

By:

Guirguis, Erenie;
Dougherty, John;
Thornby, Krisy;
Grace, Yasmin;
Mack, Keri

Publication type:

Literature Review

Therapeutic Effects of MicroRNAs on Nonalcoholic Fatty Liver Disease (NAFLD) and Nonalcoholic Steatohepatitis (NASH): A Systematic Review and Meta-analysis.

Published in:

Malaysian Journal of Medicine & Health Sciences, 2024, v. 20, p. 71

By:

Yuezhi Zhu;
Jen Kit Tan;
Sok Kuan Wong;
Jo Aan Goon

Publication type:

Article

Comorbidities and healthcare costs and resource use of patients with nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH) in the Japan medical data vision database.

Published in:

Journal of Gastroenterology, 2021, v. 56, n. 3, p. 274, doi. 10.1007/s00535-021-01759-2

By:

Terai, Shuji;
Buchanan-Hughes, Amy;
Ng, Alvin;
Lee, I-Heng;
Hasegawa, Ken

Publication type:

Article

The methyltransferase METTL3 negatively regulates nonalcoholic steatohepatitis (NASH) progression.

Published in:

Nature Communications, 2021, v. 12, n. 1, p. 1, doi. 10.1038/s41467-021-27539-3

By:

Li, Xinzhi;
Yuan, Bingchuan;
Lu, Min;
Wang, Yuqin;
Ding, Na;
Liu, Chunhong;
Gao, Ming;
Yao, Zhicheng;
Zhang, Shiyan;
Zhao, Yujun;
Xie, Liwei;
Chen, Zheng

Publication type:

Article

Nonalcoholic Steatohepatitis (NASH) Does Not Increase Complications After Laparoscopic Bariatric Surgery.

Published in:

Obesity Surgery, 2011, v. 21, n. 11, p. 1714, doi. 10.1007/s11695-011-0521-z

By:

Weingarten, Toby;
Swain, James;
Kendrick, Michael;
Charlton, Michael;
Schroeder, Brent;
Lee, Robert;
Narr, Bradly;
Ribeiro, Tarsila;
Schroeder, Darrell;
Sprung, Juraj

Publication type:

Article

Identification of FDFT1 and PGRMC1 as New Biomarkers in Nonalcoholic Steatohepatitis (NASH)-Related Hepatocellular Carcinoma by Deep Learning.

Published in:

Journal of Hepatocellular Carcinoma, 2025, v. 12, p. 685, doi. 10.2147/JHC.S505752

By:

Liu, Qiqi;
Yang, Yinuo;
Wang, Yongshuai;
Wei, Shuhang;
Yang, Liu;
Liu, Tiantian;
Yu, Zhen;
Feng, Yuemin;
Yao, Ping;
Zhu, Qiang

Publication type:

Article

Front Cover: Soyasaponin A2 Alleviates Steatohepatitis Possibly through Regulating Bile Acids and Gut Microbiota in the Methionine and Choline‐Deficient (MCD) Diet‐induced Nonalcoholic Steatohepatitis (NASH) Mice.

Published in:

Molecular Nutrition & Food Research, 2021, v. 65, n. 15, p. 1, doi. 10.1002/mnfr.202170036

By:

Han, Lihua;
Du, Min;
Ren, Fazheng;
Mao, Xueying

Publication type:

Article

Soyasaponin A2 Alleviates Steatohepatitis Possibly through Regulating Bile Acids and Gut Microbiota in the Methionine and Choline‐Deficient (MCD) Diet‐induced Nonalcoholic Steatohepatitis (NASH) Mice.

Published in:

Molecular Nutrition & Food Research, 2021, v. 65, n. 14, p. 1, doi. 10.1002/mnfr.202100067

By:

Xiong, Fei;
Zheng, Zhongdaixi;
Xiao, Lingyu;
Su, Chuhong;
Chen, Junbin;
Gu, Xiangfu;
Tang, Jiaqi;
Zhao, Yue;
Luo, Huiyu;
Zha, Longying

Publication type:

Article

Front Cover: Soyasaponin A2 Alleviates Steatohepatitis Possibly through Regulating Bile Acids and Gut Microbiota in the Methionine and Choline‐Deficient (MCD) Diet‐induced Nonalcoholic Steatohepatitis (NASH) Mice.

Published in:

Molecular Nutrition & Food Research, 2021, v. 65, n. 14, p. 1, doi. 10.1002/mnfr.202100067

By:

Xiong, Fei;
Zheng, Zhongdaixi;
Xiao, Lingyu;
Su, Chuhong;
Chen, Junbin;
Gu, Xiangfu;
Tang, Jiaqi;
Zhao, Yue;
Luo, Huiyu;
Zha, Longying

Publication type:

Article

Effect of Metformin on Ballooning Degeneration in Nonalcoholic Steatohepatitis (NASH): When to Use Metformin in Nonalcoholic Fatty Liver Disease (NAFLD).

Published in:

Advances in Therapy, 2014, v. 31, n. 1, p. 30, doi. 10.1007/s12325-013-0084-6

By:

Doycheva, Iliana;
Loomba, Rohit

Publication type:

Article